List of Excipients in API BUMETANIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BUMETANIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Validus Pharmaceuticals LLC | BUMEX | bumetanide | 30698-630 | ANHYDROUS LACTOSE | |
| Validus Pharmaceuticals LLC | BUMEX | bumetanide | 30698-630 | CELLULOSE, MICROCRYSTALLINE | |
| Validus Pharmaceuticals LLC | BUMEX | bumetanide | 30698-630 | D&C YELLOW NO. 10 | |
| Validus Pharmaceuticals LLC | BUMEX | bumetanide | 30698-630 | FD&C BLUE NO. 1 | |
| Validus Pharmaceuticals LLC | BUMEX | bumetanide | 30698-630 | MAGNESIUM STEARATE | |
| Validus Pharmaceuticals LLC | BUMEX | bumetanide | 30698-630 | STARCH, CORN | |
| Validus Pharmaceuticals LLC | BUMEX | bumetanide | 30698-630 | TALC | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BUMETANIDE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Eon Labs Inc | bumetanide | 0185-0128 | ANHYDROUS LACTOSE |
| Eon Labs Inc | bumetanide | 0185-0128 | CELLULOSE, MICROCRYSTALLINE |
| Eon Labs Inc | bumetanide | 0185-0128 | D&C YELLOW NO. 10 |
| Eon Labs Inc | bumetanide | 0185-0128 | FD&C BLUE NO. 1 |
| Eon Labs Inc | bumetanide | 0185-0128 | FD&C RED NO. 40 |
| Eon Labs Inc | bumetanide | 0185-0128 | MAGNESIUM STEARATE |
| Eon Labs Inc | bumetanide | 0185-0128 | STARCH, CORN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for BUMETANIDE
Excipient focus: ALUMINUM OXIDE
BUMETANIDE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | bumetanide | 0615-4536 |
| Aidarex Pharmaceuticals LLC | bumetanide | 33261-983 |
| Carilion Materials Management | bumetanide | 68151-0087 |
| >Company | >Ingredient | >NDC |
BUMETANIDE drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIUM ACETATE
BUMETANIDE drug variants containing AMMONIUM ACETATE
BUMETANIDE drug variants not containing AMMONIUM ACETATE
Excipient focus: ANHYDROUS LACTOSE
BUMETANIDE drug variants containing ANHYDROUS LACTOSE
BUMETANIDE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BENZYL ALCOHOL
BUMETANIDE drug variants containing BENZYL ALCOHOL
BUMETANIDE drug variants not containing BENZYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
BUMETANIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
BUMETANIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: D&C YELLOW NO. 10
BUMETANIDE drug variants containing D&C YELLOW NO. 10
BUMETANIDE drug variants not containing D&C YELLOW NO. 10
Excipient focus: EDETATE DISODIUM
BUMETANIDE drug variants containing EDETATE DISODIUM
BUMETANIDE drug variants not containing EDETATE DISODIUM
Excipient focus: FD&C BLUE NO. 1
BUMETANIDE drug variants containing FD&C BLUE NO. 1
BUMETANIDE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
BUMETANIDE drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | bumetanide | 51672-4223 |
| >Company | >Ingredient | >NDC |
BUMETANIDE drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2
BUMETANIDE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | bumetanide | 0832-0540 |
| >Company | >Ingredient | >NDC |
BUMETANIDE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
BUMETANIDE drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Eon Labs Inc | bumetanide | 0185-0128 |
| A-S Medication Solutions | bumetanide | 50090-6308 |
| Taro Pharmaceuticals USA Inc | bumetanide | 51672-4223 |
| Physicians Total Care Inc | bumetanide | 54868-3765 |
| Bryant Ranch Prepack | bumetanide | 72162-2195 |
| >Company | >Ingredient | >NDC |
BUMETANIDE drug variants not containing FD&C RED NO. 40
Excipient focus: FERRIC OXIDE RED
BUMETANIDE drug variants containing FERRIC OXIDE RED
BUMETANIDE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
BUMETANIDE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | bumetanide | 0832-0540 |
| Aphena Pharma Solutions - Tennessee LLC | bumetanide | 43353-292 |
| A-S Medication Solutions | bumetanide | 50090-6304 |
| Bryant Ranch Prepack | bumetanide | 72162-2197 |
| >Company | >Ingredient | >NDC |
BUMETANIDE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
BUMETANIDE drug variants containing FERROSOFERRIC OXIDE
BUMETANIDE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: LACTOSE MONOHYDRATE
BUMETANIDE drug variants containing LACTOSE MONOHYDRATE
BUMETANIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
BUMETANIDE drug variants containing MAGNESIUM STEARATE
BUMETANIDE drug variants not containing MAGNESIUM STEARATE
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
BUMETANIDE drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | bumetanide | 16571-679 |
| >Company | >Ingredient | >NDC |
BUMETANIDE drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: POVIDONE K30
BUMETANIDE drug variants containing POVIDONE K30
BUMETANIDE drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
BUMETANIDE drug variants containing SILICON DIOXIDE
BUMETANIDE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CHLORIDE
BUMETANIDE drug variants containing SODIUM CHLORIDE
BUMETANIDE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
BUMETANIDE drug variants containing SODIUM HYDROXIDE
BUMETANIDE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
BUMETANIDE drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | bumetanide | 16571-679 |
| >Company | >Ingredient | >NDC |
BUMETANIDE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
BUMETANIDE drug variants containing STARCH, CORN
BUMETANIDE drug variants not containing STARCH, CORN
Excipient focus: TALC
BUMETANIDE drug variants containing TALC
BUMETANIDE drug variants not containing TALC
Excipient focus: WATER
BUMETANIDE drug variants containing WATER
BUMETANIDE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
